Canaccord Genuity Group Forecasts Strong Price Appreciation for Calian Group (TSE:CGY) Stock

Calian Group (TSE:CGY) had its target price upped by stock analysts at Canaccord Genuity Group from C$60.00 to C$63.00 in a report released on Thursday,BayStreet.CA reports. The firm currently has a “buy” rating on the stock. Canaccord Genuity Group’s price target suggests a potential upside of 16.43% from the stock’s current price.

Other equities research analysts have also recently issued research reports about the company. Ventum Financial decreased their price target on Calian Group from C$60.00 to C$58.00 and set a “buy” rating for the company in a report on Thursday, August 14th. Royal Bank Of Canada upped their price objective on shares of Calian Group from C$58.00 to C$66.00 and gave the stock an “outperform” rating in a research report on Thursday. CIBC lifted their target price on shares of Calian Group from C$59.00 to C$62.00 and gave the company an “outperform” rating in a report on Wednesday, October 29th. Finally, Desjardins cut their price target on shares of Calian Group from C$62.00 to C$59.00 and set a “buy” rating for the company in a report on Thursday, August 14th. Five equities research analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, the company currently has an average rating of “Buy” and a consensus target price of C$63.80.

Calian Group Stock Up 2.5%

CGY opened at C$54.11 on Thursday. Calian Group has a 52 week low of C$37.70 and a 52 week high of C$54.35. The business has a 50 day moving average price of C$50.48 and a two-hundred day moving average price of C$48.76. The company has a quick ratio of 1.20, a current ratio of 1.29 and a debt-to-equity ratio of 39.54. The company has a market cap of C$613.88 million, a PE ratio of -901.83, a P/E/G ratio of 2.50 and a beta of 0.43.

Calian Group Company Profile

Calian Group Ltd operates through four segments namely Advanced Technologies, Health, Learning, and Information Technology. It generates maximum revenue from the Health segment. The company serves health, defence, security, aerospace, engineering, AgTech, and IT industries. Its Health segment includes Clinical Services; Nursing Services; Psychological Services and Medical Property Management.